CDK9-IN-26

• UNSPSC Description:

  CDK9-IN-26 (compound 1is a CDK9 inhibitor (IC50=0.18 μM). [1].

• Target Antigen:

  CDK

• Type:

  Reference compound

• Related Pathways:

  Cell Cycle/DNA Damage

• Applications:

  Cancer-Kinase/protease

• Field of Research:

  cancer

• Assay Protocol:

  https://www.medchemexpress.com/cdk9-in-26.html

• Solubility:

  10 mM in DMSO

• Smiles:

  COC1=CC=C(NC2=C(C3=COC=C3)N=C4C=NC=CN42)C=C1

• Molecular Weight:

  306.32

• References & Citations:

  [1]Alsfouk AA, et al. New Imadazopyrazines with CDK9 Inhibitory Activity as Anticancer and Antiviral: Synthesis, In Silico, and In Vitro Evaluation Approaches. Pharmaceuticals (Basel). 2023 Jul 18;16(7):1018.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported